Expert Systems, Inc. works across drug discovery and development from target identification through clinical development.
The company deploys a hybrid AI/ML-based platform for preclinical drug discovery and early development.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Its R&D program management work is for financial investors and strategic partners.
The platform covers preclinical drug discovery and early development, including target identification, virtual screening, non-clinical and clinical pharmacology, chemical liability assessment, and toxicology.
Source: LinkedIn company description · Retrieved October 13, 2026
The company uses proprietary and public databases and software tools to evaluate intellectual property landscapes and provide competitive intelligence.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.Snapshot: September 10, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 10, 2026, September 18, 2026, September 26, 2026, September 27, 2026, September 28, 2026 and September 30, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.